APPLE - 54575-335-02 - (apple)

Alphabetical Index


Drug Information of APPLE

Product NDC: 54575-335
Proprietary Name: APPLE
Non Proprietary Name: apple
Active Ingredient(s): 1    g/20mL & nbsp;   apple
Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of APPLE

Product NDC: 54575-335
Labeler Name: Allergy Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA101376
Marketing Category: BLA
Start Marketing Date: 19671207

Package Information of APPLE

Package NDC: 54575-335-02
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (54575-335-02)

NDC Information of APPLE

NDC Code 54575-335-02
Proprietary Name APPLE
Package Description 2 mL in 1 VIAL, MULTI-DOSE (54575-335-02)
Product NDC 54575-335
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name apple
Dosage Form Name INJECTION, SOLUTION
Route Name PERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date 19671207
Marketing Category Name BLA
Labeler Name Allergy Laboratories, Inc.
Substance Name APPLE
Strength Number 1
Strength Unit g/20mL
Pharmaceutical Classes Allergens [Chemical/Ingredient],Dietary Proteins [Chemical/Ingredient],Fruit Proteins [Chemical/Ingredient],Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE]

Complete Information of APPLE


General Information